Life-saving cancer drug a boon to patients in Japan, but price prompts debate
This photo shows vials of the drug Opdivo. (Photo courtesy of Ono Pharmaceutical Co.)(Kyodo) TOKYO (Kyodo) -- Nivolumab, an immune checkpoint inhibitor lauded for its groundbreaking approach to cancer treatment, marked its 10th anniversary this month since …